Nabriva Therapeutics Plc

NBRVF

OTCHealth Care

Income Statement

Total Revenue$30.36M

Gross Profit$12.61M

Operating Income$-33.9M

EBITDA$-33.94M

EBIT$-34.02M

Pre-tax Income$-54.22M

Net Income$-34.8M

Cash Equivalent$1.92M

Total Debt$542K

Book Value$-4.36M

Book Value Per Share-1.42

Return on Equity (ROE)-1733.03%

Return on Assets (ROA)-179.84%

Return on Invested Capital (ROI)-672.82%

Net Profit Margin-154.82%

Current Ratio1.13

Quick Ratio0.70

Long-Term Debt / Equity0.12